MLchartDataset catalogue

L-MTP-PE

Term · Oncology and biomedicine · MLC-T-ONC-004892

A drug being studied in the treatment of young adults with bone cancer that has gotten worse or come back. L-MTP-PE activates certain types of white blood cells and helps the immune system kill cancer cells. It is a type of immunostimulant. Also called MEPACT, mifamurtide, and muramyl tripeptide phosphatidylethanolamine.

Table 1. Record
IdentifierMLC-T-ONC-004892
FieldOncology and biomedicine
Expansionsmifamurtide; muramyl tripeptide phosphatidylethanolamine
SynonymsMEPACT
ReferencesNCI Dictionary of Cancer Terms
Record as JSON
{
  "id": "MLC-T-ONC-004892",
  "term": "L-MTP-PE",
  "field": "Oncology and biomedicine",
  "definition": "A drug being studied in the treatment of young adults with bone cancer that has gotten worse or come back. L-MTP-PE activates certain types of white blood cells and helps the immune system kill cancer cells. It is a type of immunostimulant. Also called MEPACT, mifamurtide, and muramyl tripeptide phosphatidylethanolamine.",
  "expansions": [
    "mifamurtide",
    "muramyl tripeptide phosphatidylethanolamine"
  ],
  "synonyms": [
    "MEPACT"
  ],
  "references": [
    "NCI Dictionary of Cancer Terms"
  ],
  "url": "https://mlchart.com/terminology/oncology/l-mtp-pe/"
}

Record 10,256 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.